Robotic catheter system market seen hitting $1.75 billion by 2030

The robotic catheter system market is projected to grow from $1.03 billion in 2026 to $1.75 billion by 2030, driven by demand for less invasive procedures, AI-enabled navigation and expanding use in cardiovascular and neurovascular care. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Robotic catheter systems are gaining traction in procedures that demand precision, including cardiovascular, neurovascular and electrophysiology treatments. - The technology supports less invasive care, which can reduce radiation exposure for clinicians and improve patient safety and outcomes. - The market’s growth signals broader adoption of robotic-assisted tools in hospitals and outpatient interventional settings.

What happened: - The Business Research Company released a report projecting the robotic catheter system market to reach $1.75 billion by 2030. - The market is expected to rise from $0.9 billion in 2025 to $1.03 billion in 2026. - The forecast implies a 14.1% compound annual growth rate from 2025 to 2026 and a 14.3% CAGR through 2030. - The report was published Sept. 14, 2026, in London. - A free sample of the report is available here. - The full report is available here.

The details: - The report points to rising adoption of robotic-assisted surgical technologies, AI-powered navigation and imaging, outpatient interventional procedures and demand for patient-specific interventions. - Growth in past years has been supported by rising cardiovascular and neurovascular disease prevalence. - Expansion of hospital catheterization labs has helped accelerate adoption. - Physician training programs have improved readiness to use robotic catheter systems. - The systems are used to maneuver catheters inside the body during minimally invasive procedures. - Compared with manual handling, the systems provide greater stability, control and accuracy. - Cardiovascular disease growth includes coronary artery disease, heart failure, arrhythmias and stroke. - In September 2025, the Heart Failure Society of America reported about 6.7 million Americans over age 20 were living with heart failure, with that number projected to reach 8.7 million by 2030, 10.3 million by 2040 and 11.4 million by 2050. - Minimally invasive procedures are increasing because they can shorten recovery time and reduce surgical risks. - Data from the American Society of Plastic Surgeons in June 2024 showed a 7% increase in minimally invasive procedures in 2023, compared with a 2% rise in traditional surgeries. - Healthcare spending is also supporting adoption of advanced robotic systems. - The Office for National Statistics said UK healthcare spending rose 6.5% from 2023 to 2024, after 6.3% growth in the prior year.

Between the lines: - The market forecast suggests robotic catheter systems are moving from niche tools toward standard infrastructure in advanced interventional care. - AI-enabled navigation and imaging appear to be shifting from optional upgrades to core features that can help tackle more complex cases. - The regional split suggests mature healthcare systems are buying first, while faster growth is likely to come from markets still expanding access to advanced medical technology. - The report also highlights a broader industry push toward systems that can improve efficiency while lowering risk for both patients and clinicians.

What's next: - North America is expected to remain a major market after holding the largest share in 2025. - Asia-Pacific is projected to be the fastest-growing region in the coming years. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The Business Research Company said its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables.

The bottom line: - Robotic catheter systems are moving into a strong growth phase as hospitals look for more accurate, safer and less invasive ways to treat complex cardiovascular and neurovascular disease.